======= CENPL ======= == Gene Information == * **Official Symbol**: CENPL * **Official Name**: centromere protein L * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=91687|91687]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N0S6|Q8N0S6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CENPL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CENPL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611503|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex. {ECO:0000269|PubMed:16716197}. No Pfam Domain information is available for this gene. |CENP-A containing nucleosome assembly| |CENP-A containing chromatin organization| |chromatin remodeling at centromere| |centromere complex assembly| |DNA replication-independent nucleosome assembly| |DNA replication-independent nucleosome organization| |histone exchange| |chromosome, centromeric region| |ATP-dependent chromatin remodeling| |nucleosome assembly| |chromatin assembly| |chromatin assembly or disassembly| |nucleosome organization| |chromatin remodeling| |DNA packaging| |protein-DNA complex assembly| |protein-DNA complex subunit organization| |DNA conformation change| |chromatin organization| |cellular protein-containing complex assembly| |chromosome organization| |protein-containing complex assembly| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-2.93| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.66| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.5| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-2.44| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.16| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|-2.08| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-1.93| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.85| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.75| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.92| ^Gene^Correlation^ |[[:human genes:c:cenpq|CENPQ]]|0.461| |[[:human genes:c:cenpp|CENPP]]|0.434| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1428 * **Expression level (log2 read counts)**: 5.06 {{:chemogenomics:nalm6 dist.png?nolink |}}